Attendee search 

Chugai Pharma Europe Ltd. is seeking for in-licensing and partnering opportunities for its European key territories in UK, Germany and France. We strive to build our business model on existing partnerships in oncology/hematology and rheumatology as well as to grow as a organization with strong commercialization expertise, broad market access and pricing knowledge and valuable experience in medical advocacy and KOL Management.

We look forward to meeting you in Montreux,

Ryo ishimura and Florian Streckert 

Leader in consensus forecast analysis of the biotech and pharma sector providing trusted insight into global performance to 2024.

Three factors have led to large experience in licenses and collaborations:

• The consolidated presence of the Juste Group in the Spanish, Central American, and South American markets.
• Our in-house developed products.
• The growing prestige of the company since its beginning.

The Juste Group has a permanent interest in collaborating with development projects and establish license agreements and/or co-promotion for Spain, Portugal, countries from Central and South America, Middle East, and North Africa in the following fields of specialization:

• Radiology/Contrast medium

Specialized Pharma M&A Boutique operating since 1991 globally

Max Zeller Söhne AG specialises in the development, production and marketing of phyto-pharmaceuticals with clinically proven efficacy, safety and tolerability. 

Zeller is a leader in the Swiss market for phyto-pharmaceuticals and one of the few companies that controls the entire value chain from seed to finished product. At the Zeller sites in Romanshorn and Uttwil (VitaPlant), there are 135 employees in diverse disciplines such as biology, agriculture, process engineering, pharmacy and medicine. Patients benefit from Zeller’s phyto-pharmaceuticals both in Switzerland and worldwide.

Consultant

Roche Diagnostics GmbH